Xiaoyuan Lu
- Molecular Biology
- Organic Chemistry top 10%
- Cancer Research
- Pharmacology
- Pulmonary and Respiratory Medicine
- Co-authors
- Hai‐Liang ZhuRobert M. PearlsteinZhong‐Chang WangFa-Qian ShenShen‐Zhen RenSicong LiuRuo‐Jun ManXiaoqiang Yan
- Topics
- Cancer-related molecular mechanisms research (8 papers)RNA modifications and cancer (7 papers)Circular RNAs in diseases (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONERSC Advances
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Xiaoyuan Lu
24 papers receiving 428 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 250
- Organic Chemistry 186
- Cancer Research 110
- Pharmacology 65
- Pulmonary and Respiratory Medicine 40
Countries citing papers authored by Xiaoyuan Lu
This map shows the geographic impact of Xiaoyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Lu more than expected).
Fields of papers citing papers by Xiaoyuan Lu
This network shows the impact of papers produced by Xiaoyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Lu. The network helps show where Xiaoyuan Lu may publish in the future.
Co-authorship network of co-authors of Xiaoyuan Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Lu. A scholar is included among the top collaborators of Xiaoyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Lu. Xiaoyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 8 | |
| 7 | 19 | |
| 8 | 13 | |
| 9 | 21 | |
| 10 | 11 | |
| 11 | LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway. | 7 |
| 12 | 47 | |
| 13 | 76 | |
| 14 | 14 | |
| 15 | 36 | |
| 16 | 25 | |
| 17 | 28 | |
| 18 | 6 | |
| 19 | Effects of RNA interference targeting OPN on the in vitro proliferation of human ovarian cancer cell line HO-8910PM | 1 |
| 20 | [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer]. | 3 |
About Xiaoyuan Lu
Xiaoyuan Lu is a scholar working on Cancer Research, Pharmacology and Organic Chemistry, having authored 25 papers that have together received 441 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (110 citations), Organic Chemistry (186 citations) and Toxicology (14 citations). Xiaoyuan Lu has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Hai‐Liang Zhu, Robert M. Pearlstein, Zhong‐Chang Wang, Fa-Qian Shen, Shen‐Zhen Ren, Sicong Liu, Ruo‐Jun Man, Xiaoqiang Yan, Pengfei Wang and Juan Sun. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.